Theo Pelzer
Senior Physician
Department of Internal Medicine I, Pneumology
The Julius Maximilian University of Wurzburg
Germany
Biography
Education and Training 1985–1991 Studies of Medicine at the Universities of Bonn, Berlin (Charité), Vienna and Mainz 1991 Scientific doctorate Dr. med., University Bonn (Prof. Vetter) 2002 Consultant in Internal Medicine 2004 & 2008 Consultant in Cardiology and Pneumology Positions and Employment 1991–1994 Post-doctoral fellowship at the Southwestern Medical Center/University of Texas in Dallas/USA, (Prof. R.S. Williams) 1994–1995 Internship at the Department of Medicine, University of Bonn (Prof. H. Vetter) 1995–ongoing Consultant of Internal Medicine and Cardiology at the Department of Medicine, University of Würzburg (Prof. Prof. G. Ertl) 2008 Assistant Professor of Internal Medicine – Cardiology & Pneumology at the Department of Medicine, University of Würzburg
Research Interest
 Main interests Cardiovascular effects of steroid and female sex hormones – pulmonary hypertension (clinical and experimental studies) – cardiovascular effects of obesity and type-2 diabetes  Ongoing research support o IMPRES (CQTI571A2301E1) – clinical phase III trial on imatinib in pulmonary hypertension o IMPACT (CQTI571ADE02) – clinical phase III trial on nilotinib in pulmonary hypertension o Bayer AG – evaluation of a novel rodent model mimicking human chronic thromboembolic pulmonary hypertension (CTEPH)
Publications
-
Periodization effects during short-term resistance training with equated exercise variables in females. Peptide Receptor Radionuclide Therapy for Sarcoidosis. Impact of tissue photon attenuation in small animal cardiac PET imaging. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. . Neuromuscular Responses to Short-Term Resistance Training With Traditional and Daily Undulating Periodization in Adolescent Elite Judoka. Development and Characterization of an Inducible Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
